Effects of Cysteinyl-Leukotriene Receptor Antagonist, Thromboxane A2 Receptor Antagonist, and Thromboxane A2 Synthetase Inhibitor on Antigen-Induced Bronchoconstriction in Patients With Asthma
Authors:
- Yasushi ObaseYOYasushi Obase
- Terufumi ShimodaTSTerufumi Shimoda
- Nobuko MatsuoNMNobuko Matsuo
- Hiroto MatsuseHMHiroto Matsuse
- Sadahiro AsaiSASadahiro Asai
- Shigeru KohnoSKShigeru Kohno
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- The effect of an oral leukotriene antagonist, ONO-1078, on allergen-induced immediate bronchoconstriction in asthmatic subjectsJournal of Allergy and Clinical Immunology, 1993
- Effect of cysteinyl-leukotriene receptor antagonist ICI 204.219 on allergen-induced bronchoconstriction and airway hyperreactivity in atopic subjectsThe Lancet, 1991
- Evidence for Elevated Levels of Histamine, Prostaglandin D2, and Other Bronchoconstricting Prostaglandins in the Airways of Subjects with Mild AsthmaAmerican Review of Respiratory Disease, 1990
- Allergen-stimulated Release of Thromboxane A2 and Leukotriene E4 in Humans: Effect of IndomethacinAmerican Review of Respiratory Disease, 1990
- Clinical Implications of Prostaglandin and Thromboxane A2FormationNew England Journal of Medicine, 1988
- The effect of synthetic leukotrienes on tracheal microvascular permeabilityProstaglandins, 1983
- Leukotrienes are potent constrictors of human bronchiNature, 1980
- Thromboxane A2: Effects of airway and vascular smooth muscleProstaglandins, 1977
- Standardization of bronchial inhalation challenge proceduresJournal of Allergy and Clinical Immunology, 1975
- Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides.Proceedings of the National Academy of Sciences, 1975